What are the brand name prescription medicines for Helicobacter pylori (H. pylori) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Brand Name Prescription Medications for H. pylori Infection

The most effective brand name prescription medications for H. pylori infection include Talicia® (rifabutin-based triple therapy), Pylera® (bismuth quadruple therapy), and PPI-based combination regimens such as Prevpac® (lansoprazole, amoxicillin, and clarithromycin). 1, 2

First-Line Treatment Options

Bismuth Quadruple Therapy

  • Pylera® - Contains bismuth subcitrate potassium, metronidazole, and tetracycline combined with a PPI
  • Prevpac® - Contains lansoprazole, amoxicillin, and clarithromycin in a convenient package
  • Omeclamox-Pak® - Contains omeprazole, clarithromycin, and amoxicillin

PPI Components (Brand Names)

  • Nexium® (esomeprazole)
  • Protonix® (pantoprazole)
  • Prevacid® (lansoprazole)
  • Prilosec® (omeprazole)
  • Aciphex® (rabeprazole)

Treatment Selection Based on Antibiotic Resistance

Areas with Low Clarithromycin Resistance (<15%)

  • Standard Triple Therapy (14 days): PPI (Nexium® or Aciphex®) + clarithromycin + amoxicillin 2
    • PPI (standard dose) twice daily
    • Clarithromycin 500mg twice daily
    • Amoxicillin 1000mg twice daily

Areas with High Clarithromycin Resistance (≥15%)

  • Bismuth Quadruple Therapy (14 days): PPI + Pylera® 2
  • Talicia® - FDA-approved rifabutin-based triple therapy containing rifabutin, amoxicillin, and omeprazole 1

Second-Line Treatment Options

If first-line treatment fails, options include:

  • Levofloxacin-based triple therapy (in areas with low fluoroquinolone resistance) 2, 3

    • PPI (standard dose) twice daily
    • Levofloxacin 500mg once daily or 250mg twice daily
    • Amoxicillin 1000mg twice daily
  • Rifabutin triple therapy (14 days) 1, 2

    • Rifabutin 150mg twice daily
    • Amoxicillin 1g three times daily
    • PPI (preferably esomeprazole or rabeprazole) 40mg twice daily

Important Considerations

  1. PPI Selection: Higher-potency PPIs like Nexium® (esomeprazole) or Aciphex® (rabeprazole) at 40mg twice daily are more effective than lower-potency options 1

  2. Treatment Duration: All regimens should be administered for 14 days to increase eradication rates by approximately 5% 2

  3. Medication Timing: PPIs should be taken 30 minutes before meals on an empty stomach to maximize effectiveness 2

  4. Confirmation of Eradication: Urea breath test or monoclonal stool antigen test should be performed at least 4 weeks after completing treatment, with PPIs discontinued at least 2 weeks before testing 2

  5. Antibiotic Resistance: After two treatment failures, antimicrobial susceptibility testing should guide further treatment whenever possible 2, 4

Common Pitfalls to Avoid

  1. Inadequate PPI Dosing: Using once-daily PPI instead of twice-daily reduces efficacy 2

  2. Insufficient Treatment Duration: Less than 14 days results in lower eradication rates 2

  3. Reusing Failed Antibiotics: Avoid using the same antibiotic after therapeutic failure, particularly clarithromycin 2

  4. Ignoring Penicillin Allergy: For patients with penicillin allergy, bismuth-containing quadruple therapy is recommended as first-line treatment 2

  5. Overlooking Drug Interactions: Be aware of potential interactions between PPIs and other medications 5

By following these evidence-based recommendations and selecting appropriate brand name medications, H. pylori eradication rates of over 80% can be achieved, reducing the risk of peptic ulcer disease recurrence and potential complications like gastric cancer.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

H. pylori Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

The American journal of gastroenterology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.